{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T07:41:22Z","timestamp":1764229282799,"version":"3.46.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,26]]},"DOI":"10.7759\/cureus.97903","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T07:39:11Z","timestamp":1764229151000},"source":"Crossref","is-referenced-by-count":0,"title":["A Systematic Review on the Effect of Colchicine in Cardiovascular Disease Management: From Risk Reduction to Comprehensive Care"],"prefix":"10.7759","author":[{"given":"Faysal","family":"Azani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad A","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athar Naveed","family":"Yasin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zill E","family":"Huma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Aldujeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahid U","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-021-00835-w","article-title":"Therapeutic potential of colchicine in cardiovascular medicine: a pharmacological review","volume":"43","author":"Zhang FS","year":"2022","unstructured":"Zhang FS, He QZ, Qin CH, Little PJ, Weng JP, Xu SW. Therapeutic potential of colchicine in cardiovascular medicine: a pharmacological review. Acta Pharmacol Sin. 2022, 43:2173-90. 10.1038\/s41401-021-00835-w","journal-title":"Acta Pharmacol Sin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2174\/1871523011312010004","article-title":"Colchicine: an old wine in a new bottle?","volume":"12","author":"Roubille F","year":"2013","unstructured":"Roubille F, Kritikou E, Busseuil D, Barrere-Lemaire S, Tardif JC. Colchicine: an old wine in a new bottle?. Antiinflamm Antiallergy Agents Med Chem. 2013, 12:14-23. 10.2174\/1871523011312010004","journal-title":"Antiinflamm Antiallergy Agents Med Chem"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15896","article-title":"Colchicine: an ancient drug with novel applications","volume":"178","author":"Dasgeb B","year":"2018","unstructured":"Dasgeb B, Kornreich D, McGuinn K, Okon L, Brownell I, Sackett DL. Colchicine: an ancient drug with novel applications. Br J Dermatol. 2018, 178:350-6. 10.1111\/bjd.15896","journal-title":"Br J Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2174\/1381612826666201023144320","article-title":"Colchicine: an ancient drug with multiple benefits","volume":"27","author":"El Hasbani G","year":"2021","unstructured":"El Hasbani G, Jawad A, Uthman I. Colchicine: an ancient drug with multiple benefits. Curr Pharm Des. 2021, 27:2917-24. 10.2174\/1381612826666201023144320","journal-title":"Curr Pharm Des"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/cells13171471","article-title":"A comprehensive review of cardiovascular disease management: cardiac biomarkers, imaging modalities, pharmacotherapy, surgical interventions, and herbal remedies","volume":"13","author":"Netala VR","year":"2024","unstructured":"Netala VR, Teertam SK, Li H, Zhang Z. A comprehensive review of cardiovascular disease management: cardiac biomarkers, imaging modalities, pharmacotherapy, surgical interventions, and herbal remedies. Cells. 2024, 13:10.3390\/cells13171471","journal-title":"Cells"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.06.037","article-title":"Colchicine in patients with chronic coronary disease in relation to prior acute coronary syndrome","volume":"78","author":"Opstal TS","year":"2021","unstructured":"Opstal TS, Fiolet AT, van Broekhoven A, et al.. Colchicine in patients with chronic coronary disease in relation to prior acute coronary syndrome. J Am Coll Cardiol. 2021, 78:859-66. 10.1016\/j.jacc.2021.06.037","journal-title":"J Am Coll Cardiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2459\/JCM.0000000000001079","article-title":"Colchicine for the treatment of cardiovascular diseases: old drug, new targets","volume":"22","author":"Andreis A","year":"2021","unstructured":"Andreis A, Imazio M, De Ferrari GM. Colchicine for the treatment of cardiovascular diseases: old drug, new targets. J Cardiovasc Med (Hagerstown). 2021, 22:1-8. 10.2459\/JCM.0000000000001079","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202201469R","article-title":"Colchicine exerts anti-atherosclerotic and -plaque-stabilizing effects targeting foam cell formation","volume":"37","author":"Schwarz N","year":"2023","unstructured":"Schwarz N, Fernando S, Chen YC, et al.. Colchicine exerts anti-atherosclerotic and -plaque-stabilizing effects targeting foam cell formation. FASEB J. 2023, 37:e22846. 10.1096\/fj.202201469R","journal-title":"FASEB J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1101\/2023.10.03.560632","article-title":"Colchicine promotes atherosclerotic plaque stability independently of inflammation","author":"Li W","year":"2023","unstructured":"Li W, Lin A, Hutton M, et al.. Colchicine promotes atherosclerotic plaque stability independently of inflammation. bioRxiv. 2023, 10.1101\/2023.10.03.560632","journal-title":"bioRxiv"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2174\/1381612824666180123110042","article-title":"Colchicine pharmacokinetics and mechanism of action","volume":"24","author":"Angelidis C","year":"2018","unstructured":"Angelidis C, Kotsialou Z, Kossyvakis C, et al.. Colchicine pharmacokinetics and mechanism of action. Curr Pharm Des. 2018, 24:659-63. 10.2174\/1381612824666180123110042","journal-title":"Curr Pharm Des"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1177\/1074248418763611","article-title":"Cardioprotective role of colchicine against inflammatory injury in a rat model of acute myocardial infarction","volume":"23","author":"Bakhta O","year":"2018","unstructured":"Bakhta O, Blanchard S, Guihot AL, Tamareille S, Mirebeau-Prunier D, Jeannin P, Prunier F. Cardioprotective role of colchicine against inflammatory injury in a rat model of acute myocardial infarction. J Cardiovasc Pharmacol Ther. 2018, 23:446-55. 10.1177\/1074248418763611","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahjo.2025.100525","article-title":"Colchicine therapy in cardiovascular medicine: a literature review","volume":"52","author":"Trube J","year":"2025","unstructured":"Trube J, Sabina M, Khanani A, Hernandez K, Khan Z, Bizanti A. Colchicine therapy in cardiovascular medicine: a literature review. Am Heart J Plus. 2025, 52:100525. 10.1016\/j.ahjo.2025.100525","journal-title":"Am Heart J Plus"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-024-02049-y","article-title":"Colchicine for the prevention of cardiovascular disease: potential global implementation","volume":"26","author":"Zhang RS","year":"2024","unstructured":"Zhang RS, Weber BN, Araiza-Garaygordobil D, Garshick MS. Colchicine for the prevention of cardiovascular disease: potential global implementation. Curr Cardiol Rep. 2024, 26:423-34. 10.1007\/s11886-024-02049-y","journal-title":"Curr Cardiol Rep"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-021-01828-9","article-title":"Colchicine in ischemic heart disease: the good, the bad and the ugly","volume":"110","author":"D'Amario D","year":"2021","unstructured":"D'Amario D, Cappetta D, Cappannoli L, et al.. Colchicine in ischemic heart disease: the good, the bad and the ugly. Clin Res Cardiol. 2021, 110:1531-42. 10.1007\/s00392-021-01828-9","journal-title":"Clin Res Cardiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.10.027","article-title":"Low-dose colchicine for secondary prevention of cardiovascular disease","volume":"61","author":"Nidorf SM","year":"2013","unstructured":"Nidorf SM, Eikelboom JW, Budgeon CA, Thompson PL. Low-dose colchicine for secondary prevention of cardiovascular disease. J Am Coll Cardiol. 2013, 61:404-10. 10.1016\/j.jacc.2012.10.027","journal-title":"J Am Coll Cardiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2019.09.011","article-title":"The effect of low-dose colchicine in patients with stable coronary artery disease: the LoDoCo2 trial rationale, design, and baseline characteristics","volume":"218","author":"Nidorf SM","year":"2019","unstructured":"Nidorf SM, Fiolet AT, Eikelboom JW, et al.. The effect of low-dose colchicine in patients with stable coronary artery disease: the LoDoCo2 trial rationale, design, and baseline characteristics. Am Heart J. 2019, 218:46-56. 10.1016\/j.ahj.2019.09.011","journal-title":"Am Heart J"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2022.06.009","article-title":"Efficacy of colchicine in the treatment of patients with coronary artery disease: a mini-review","volume":"44","author":"Yong J","year":"2022","unstructured":"Yong J, Tian J, Jiang W, Zhao X, Zhang H, Song X. Efficacy of colchicine in the treatment of patients with coronary artery disease: a mini-review. Clin Ther. 2022, 44:1150-9. 10.1016\/j.clinthera.2022.06.009","journal-title":"Clin Ther"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2021.07.025","article-title":"Consensus statement regarding the efficacy and safety of long-term low-dose colchicine in gout and cardiovascular disease","volume":"135","author":"Robinson PC","year":"2022","unstructured":"Robinson PC, Terkeltaub R, Pillinger MH, et al.. Consensus statement regarding the efficacy and safety of long-term low-dose colchicine in gout and cardiovascular disease. Am J Med. 2022, 135:32-8. 10.1016\/j.amjmed.2021.07.025","journal-title":"Am J Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.021198","article-title":"Colchicine in patients with coronary artery disease: a systematic review and meta\u2010analysis of randomized trials","volume":"10","author":"Kofler T","year":"2021","unstructured":"Kofler T, Kurmann R, Lehnick D, et al.. Colchicine in patients with coronary artery disease: a systematic review and meta\u2010analysis of randomized trials. J Am Heart Assoc. 2021, 10:e021198. 10.1161\/JAHA.121.021198","journal-title":"J Am Heart Assoc"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ehj.2004.02.002","article-title":"Guidelines on the diagnosis and management of pericardial diseases executive summary; the task force on the diagnosis and management of pericardial diseases of the European society of cardiology","volume":"25","author":"Maisch B","year":"2004","unstructured":"Maisch B, Seferovi\u0107 PM, Risti\u0107 AD, et al.. Guidelines on the diagnosis and management of pericardial diseases executive summary; the task force on the diagnosis and management of pericardial diseases of the European society of cardiology. Eur Heart J. 2004, 25:587-610. 10.1016\/j.ehj.2004.02.002","journal-title":"Eur Heart J"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2023.05.055","article-title":"Low-dose colchicine for secondary prevention of coronary artery disease: JACC Review Topic of the Week","volume":"82","author":"Nelson K","year":"2023","unstructured":"Nelson K, Fuster V, Ridker PM. Low-dose colchicine for secondary prevention of coronary artery disease: JACC Review Topic of the Week. J Am Coll Cardiol. 2023, 82:648-60. 10.1016\/j.jacc.2023.05.055","journal-title":"J Am Coll Cardiol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0b013e3182742cf6","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"127","author":"O'Gara PT","year":"2013","unstructured":"O'Gara PT, Kushner FG, Ascheim DD, et al.. 2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. Circulation. 2013, 127:e362-425. 10.1161\/CIR.0b013e3182742cf6","journal-title":"Circulation"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-021-02654-7","article-title":"Colchicine efficacy and safety for the treatment of cardiovascular diseases","volume":"16","author":"Andreis A","year":"2021","unstructured":"Andreis A, Imazio M, Casula M, Avondo S, De Ferrari GM. Colchicine efficacy and safety for the treatment of cardiovascular diseases. Intern Emerg Med. 2021, 16:1691-700. 10.1007\/s11739-021-02654-7","journal-title":"Intern Emerg Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-021-00932-5","article-title":"Colchicine and cardiovascular outcomes: a critical appraisal of recent studies","volume":"23","author":"Banach M","year":"2021","unstructured":"Banach M, Penson PE. Colchicine and cardiovascular outcomes: a critical appraisal of recent studies. Curr Atheroscler Rep. 2021, 23:32. 10.1007\/s11883-021-00932-5","journal-title":"Curr Atheroscler Rep"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne JA","year":"2016","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, et al.. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016, 355:i4919. 10.1136\/bmj.i4919","journal-title":"BMJ"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1411","article-title":"Risk-of-bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments","volume":"12","author":"McGuinness LA","year":"2021","unstructured":"McGuinness LA, Higgins JP. Risk-of-bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments. Res Synth Methods. 2021, 12:55-61. 10.1002\/jrsm.1411","journal-title":"Res Synth Methods"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.5867\/medwave.2021.02.8109","article-title":"The GRADE approach, Part 1: how to assess the certainty of the evidence","volume":"21","author":"Kirmayr M","year":"2021","unstructured":"Kirmayr M, Quilodr\u00e1n C, Valente B, Loezar C, Garegnani L, Franco JV. The GRADE approach, Part 1: how to assess the certainty of the evidence. Medwave. 2021, 21:e8109. 10.5867\/medwave.2021.02.8109","journal-title":"Medwave"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1002\/sim.6632","article-title":"Misunderstandings about Q and 'Cochran's Q test' in meta-analysis","volume":"35","author":"Hoaglin DC","year":"2016","unstructured":"Hoaglin DC. Misunderstandings about Q and 'Cochran's Q test' in meta-analysis. Stat Med. 2016, 35:485-95. 10.1002\/sim.6632","journal-title":"Stat Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1093\/pubmed\/fdac036","article-title":"Strengthening systematic reviews in public health: guidance in the Cochrane Handbook for Systematic Reviews of Interventions, 2nd edition","volume":"44","author":"Cumpston MS","year":"2022","unstructured":"Cumpston MS, McKenzie JE, Welch VA, Brennan SE. Strengthening systematic reviews in public health: guidance in the Cochrane Handbook for Systematic Reviews of Interventions, 2nd edition. J Public Health (Oxf). 2022, 44:e588-92. 10.1093\/pubmed\/fdac036","journal-title":"J Public Health (Oxf)"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.rec.2018.11.016","article-title":"Colchicine administered in the first episode of acute idiopathic pericarditis: a randomized multicenter open-label study","volume":"72","author":"Sambola A","year":"2019","unstructured":"Sambola A, Roca Luque I, Merc\u00e9 J, Alguersuari J, Francisco-Pascual J, Garc\u00eda-Dorado D, Sagrist\u00e0-Sauleda J. Colchicine administered in the first episode of acute idiopathic pericarditis: a randomized multicenter open-label study. Rev Esp Cardiol (Engl Ed). 2019, 72:709-16. 10.1016\/j.rec.2018.11.016","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif JC","year":"2019","unstructured":"Tardif JC, Kouz S, Waters DD, et al.. Efficacy and safety of low-dose colchicine after myocardial infarction. N Engl J Med. 2019, 381:2497-505. 10.1056\/NEJMoa1912388","journal-title":"N Engl J Med"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2019.06.003","article-title":"The Low Dose Colchicine after Myocardial Infarction (LoDoCo-MI) study: A pilot randomized placebo controlled trial of colchicine following acute myocardial infarction","volume":"215","author":"Hennessy T","year":"2019","unstructured":"Hennessy T, Soh L, Bowman M, Kurup R, Schultz C, Patel S, Hillis GS. The Low Dose Colchicine after Myocardial Infarction (LoDoCo-MI) study: A pilot randomized placebo controlled trial of colchicine following acute myocardial infarction. Am Heart J. 2019, 215:62-9. 10.1016\/j.ahj.2019.06.003","journal-title":"Am Heart J"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2019.01.054","article-title":"Effect of short-term colchicine treatment on endothelial function in patients with coronary artery disease","volume":"281","author":"Kajikawa M","year":"2019","unstructured":"Kajikawa M, Higashi Y, Tomiyama H, et al.. Effect of short-term colchicine treatment on endothelial function in patients with coronary artery disease. Int J Cardiol. 2019, 281:35-9. 10.1016\/j.ijcard.2019.01.054","journal-title":"Int J Cardiol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1042\/CS20160090","article-title":"Colchicine therapy in acute coronary syndrome patients acts on caspase-1 to suppress NLRP3 inflammasome monocyte activation","volume":"130","author":"Robertson S","year":"2016","unstructured":"Robertson S, Mart\u00ednez GJ, Payet CA, Barraclough JY, Celermajer DS, Bursill C, Patel S. Colchicine therapy in acute coronary syndrome patients acts on caspase-1 to suppress NLRP3 inflammasome monocyte activation. Clin Sci (Lond). 2016, 130:1237-46. 10.1042\/CS20160090","journal-title":"Clin Sci (Lond)"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2017.08.013","article-title":"Colchicine therapy and plaque stabilization in patients with acute\u00a0coronary syndrome: a CT coronary angiography study","volume":"11","author":"Vaidya K","year":"2018","unstructured":"Vaidya K, Arnott C, Mart\u00ednez GJ, et al.. Colchicine therapy and plaque stabilization in patients with acute\u00a0coronary syndrome: a CT coronary angiography study. JACC Cardiovasc Imaging. 2018, 11:305-16. 10.1016\/j.jcmg.2017.08.013","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.050771","article-title":"Colchicine in patients with acute coronary syndrome: the Australian COPS randomized clinical trial","volume":"142","author":"Tong DC","year":"2020","unstructured":"Tong DC, Quinn S, Nasis A, et al.. Colchicine in patients with acute coronary syndrome: the Australian COPS randomized clinical trial. Circulation. 2020, 142:1890-900. 10.1161\/CIRCULATIONAHA.120.050771","journal-title":"Circulation"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf SM","year":"2020","unstructured":"Nidorf SM, Fiolet AT, Mosterd A, et al.. Colchicine in patients with chronic coronary disease. N Engl J Med. 2020, 383:1838-47. 10.1056\/NEJMoa2021372","journal-title":"N Engl J Med"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.119.008717","article-title":"Effects of acute colchicine administration prior to percutaneous coronary intervention: COLCHICINE-PCI randomized trial","volume":"13","author":"Shah B","year":"2020","unstructured":"Shah B, Pillinger M, Zhong H, et al.. Effects of acute colchicine administration prior to percutaneous coronary intervention: COLCHICINE-PCI randomized trial. Circ Cardiovasc Interv. 2020, 13:e008717. 10.1161\/CIRCINTERVENTIONS.119.008717","journal-title":"Circ Cardiovasc Interv"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.121.056177","article-title":"Effect of colchicine on myocardial injury in acute myocardial infarction","volume":"144","author":"Mewton N","year":"2021","unstructured":"Mewton N, Roubille F, Bresson D, et al.. Effect of colchicine on myocardial injury in acute myocardial infarction. Circulation. 2021, 144:859-69. 10.1161\/CIRCULATIONAHA.121.056177","journal-title":"Circulation"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.acvd.2016.10.004","article-title":"COLIN trial: value of colchicine in the treatment of patients with acute myocardial infarction and inflammatory response","volume":"110","author":"Akodad M","year":"2017","unstructured":"Akodad M, Lattuca B, Nagot N, et al.. COLIN trial: value of colchicine in the treatment of patients with acute myocardial infarction and inflammatory response. Arch Cardiovasc Dis. 2017, 110:395-402. 10.1016\/j.acvd.2016.10.004","journal-title":"Arch Cardiovasc Dis"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2013.11.006","article-title":"Anti-inflammatory treatment with colchicine in stable chronic heart failure: a prospective, randomized study","volume":"2","author":"Deftereos S","year":"2014","unstructured":"Deftereos S, Giannopoulos G, Panagopoulou V, et al.. Anti-inflammatory treatment with colchicine in stable chronic heart failure: a prospective, randomized study. JACC Heart Fail. 2014, 2:131-7. 10.1016\/j.jchf.2013.11.006","journal-title":"JACC Heart Fail"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.01.055","article-title":"Colchicine treatment for the prevention of bare-metal stent restenosis in diabetic patients","volume":"61","author":"Deftereos S","year":"2013","unstructured":"Deftereos S, Giannopoulos G, Raisakis K, et al.. Colchicine treatment for the prevention of bare-metal stent restenosis in diabetic patients. J Am Coll Cardiol. 2013, 61:1679-85. 10.1016\/j.jacc.2013.01.055","journal-title":"J Am Coll Cardiol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(13)62709-9","article-title":"Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP- 2): a multicentre, double-blind, placebo-controlled, randomised trial","volume":"383","author":"Imazio M","year":"2014","unstructured":"Imazio M, Belli R, Brucato A, et al.. Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP- 2): a multicentre, double-blind, placebo-controlled, randomised trial. Lancet. 2014, 383:2232-7. 10.1016\/s0140-6736(13)62709-9","journal-title":"Lancet"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1315351","article-title":"A randomized trial of colchicine for acute pericarditis","volume":"370","author":"Imazio M","year":"2014","unstructured":"Imazio M, Brucato A, Adler Y. A randomized trial of colchicine for acute pericarditis. N Engl J Med. 2014, 370:781. 10.1056\/NEJMc1315351","journal-title":"N Engl J Med"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-021-02393-9","article-title":"Effects of colchicine on major adverse cardiac events in next 6-month period after acute coronary syndrome occurrence; a randomized placebo-control trial","volume":"21","author":"Akrami M","year":"2021","unstructured":"Akrami M, Izadpanah P, Bazrafshan M, Hatamipour U, Nouraein N, Drissi HB, Manafi A. Effects of colchicine on major adverse cardiac events in next 6-month period after acute coronary syndrome occurrence; a randomized placebo-control trial. BMC Cardiovasc Disord. 2021, 21:583. 10.1186\/s12872-021-02393-9","journal-title":"BMC Cardiovasc Disord"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-023-04341-9","article-title":"The low-dose colchicine in patients after non-CABG cardiac surgery: a randomized controlled trial","volume":"27","author":"Pan T","year":"2023","unstructured":"Pan T, Jiang CY, Zhang H, et al.. The low-dose colchicine in patients after non-CABG cardiac surgery: a randomized controlled trial. Crit Care. 2023, 27:49. 10.1186\/s13054-023-04341-9","journal-title":"Crit Care"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv318","article-title":"2015 ESC Guidelines for the diagnosis and management of pericardial diseases: the Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) endorsed by: the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"36","author":"Adler Y","year":"2015","unstructured":"Adler Y, Charron P, Imazio M, et al.. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: the Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) endorsed by: the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2015, 36:2921-64. 10.1093\/eurheartj\/ehv318","journal-title":"Eur Heart J"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1080\/14017431.2024.2441112","article-title":"The efficacy of colchicine compared to placebo for preventing ischemic stroke among individuals with established atherosclerotic cardiovascular diseases: a systematic review and meta-analysis","volume":"59","author":"Zhu S","year":"2025","unstructured":"Zhu S, Pan W, Yao Y, Shi K. The efficacy of colchicine compared to placebo for preventing ischemic stroke among individuals with established atherosclerotic cardiovascular diseases: a systematic review and meta-analysis. Scand Cardiovasc J. 2025, 59:2441112. 10.1080\/14017431.2024.2441112","journal-title":"Scand Cardiovasc J"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2025.103277","article-title":"Balancing the benefits and risks of colchicine use among patients with atherosclerotic cardiovascular disease: an umbrella review of meta-analyses of randomised controlled trials","volume":"84","author":"Bao RH","year":"2025","unstructured":"Bao RH, Zhao N, Jiang XF, et al.. Balancing the benefits and risks of colchicine use among patients with atherosclerotic cardiovascular disease: an umbrella review of meta-analyses of randomised controlled trials. EClinicalMedicine. 2025, 84:103277. 10.1016\/j.eclinm.2025.103277","journal-title":"EClinicalMedicine"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-013-0391-z","article-title":"Colchicine for secondary prevention of cardiovascular disease","volume":"16","author":"Nidorf SM","year":"2014","unstructured":"Nidorf SM, Eikelboom JW, Thompson PL. Colchicine for secondary prevention of cardiovascular disease. Curr Atheroscler Rep. 2014, 16:391. 10.1007\/s11883-013-0391-z","journal-title":"Curr Atheroscler Rep"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.3390\/jcdd11070206","article-title":"Systematic review on the role of IL-6 and IL-1\u03b2 in cardiovascular diseases","volume":"11","author":"Katkenov N","year":"2024","unstructured":"Katkenov N, Mukhatayev Z, Kozhakhmetov S, Sailybayeva A, Bekbossynova M, Kushugulova A. Systematic review on the role of IL-6 and IL-1\u03b2 in cardiovascular diseases. J Cardiovasc Dev Dis. 2024, 11:10.3390\/jcdd11070206","journal-title":"J Cardiovasc Dev Dis"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.15041","article-title":"Efficacy and safety of colchicine in patients with coronary artery disease: a systematic review and meta-analysis of randomized controlled trials","volume":"88","author":"Byty\u00e7i I","year":"2022","unstructured":"Byty\u00e7i I, Bajraktari G, Penson PE, Henein MY, Banach M. Efficacy and safety of colchicine in patients with coronary artery disease: a systematic review and meta-analysis of randomized controlled trials. Br J Clin Pharmacol. 2022, 88:1520-8. 10.1111\/bcp.15041","journal-title":"Br J Clin Pharmacol"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae538","article-title":"Colchicine in acutely decompensated heart failure: the COLICA trial","volume":"45","author":"Pascual-Figal D","year":"2024","unstructured":"Pascual-Figal D, N\u00fa\u00f1ez J, P\u00e9rez-Mart\u00ednez MT, et al.. Colchicine in acutely decompensated heart failure: the COLICA trial. Eur Heart J. 2024, 45:4826-36. 10.1093\/eurheartj\/ehae538","journal-title":"Eur Heart J"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0237665","article-title":"Short-term effect of low-dose colchicine on inflammatory biomarkers, lipids, blood count and renal function in chronic coronary artery disease and elevated high-sensitivity C-reactive protein","volume":"15","author":"Fiolet AT","year":"2020","unstructured":"Fiolet AT, Silvis MJ, Opstal TS, et al.. Short-term effect of low-dose colchicine on inflammatory biomarkers, lipids, blood count and renal function in chronic coronary artery disease and elevated high-sensitivity C-reactive protein. PLoS One. 2020, 15:e0237665. 10.1371\/journal.pone.0237665","journal-title":"PLoS One"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.947959","article-title":"Colchicine and coronary heart disease risks: a meta-analysis of randomized controlled clinical trials","volume":"9","author":"Ma Z","year":"2022","unstructured":"Ma Z, Chen J, Jin K, Chen X. Colchicine and coronary heart disease risks: a meta-analysis of randomized controlled clinical trials. Front Cardiovasc Med. 2022, 9:947959. 10.3389\/fcvm.2022.947959","journal-title":"Front Cardiovasc Med"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2405922","article-title":"Colchicine in acute myocardial infarction","volume":"392","author":"Jolly SS","year":"2025","unstructured":"Jolly SS, d'Entremont MA, Lee SF, et al.. Colchicine in acute myocardial infarction. N Engl J Med. 2025, 392:633-42. 10.1056\/NEJMoa2405922","journal-title":"N Engl J Med"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1093\/eurjpc\/zwaf302","article-title":"The efficacy and safety of low dose colchicine in atherosclerotic cardiovascular disease - a systematic review and meta-analysis","author":"Tucker B","year":"2025","unstructured":"Tucker B, Tucker WJ, Chung JS, Figtree GA, Keech A, Patel S. The efficacy and safety of low dose colchicine in atherosclerotic cardiovascular disease - a systematic review and meta-analysis. Eur J Prev Cardiol. 2025, 10.1093\/eurjpc\/zwaf302","journal-title":"Eur J Prev Cardiol"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2024.102878","article-title":"The effect of colchicine on myocardial infarction: an updated systematic review and meta-analysis of randomized controlled trials","volume":"50","author":"Younas A","year":"2025","unstructured":"Younas A, Awan Z, Khan T, et al.. The effect of colchicine on myocardial infarction: an updated systematic review and meta-analysis of randomized controlled trials. Curr Probl Cardiol. 2025, 50:102878. 10.1016\/j.cpcardiol.2024.102878","journal-title":"Curr Probl Cardiol"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2024.108186","article-title":"Magnitude of effect of low dose colchicine, a newly food and drug administration approved treatment for stroke prevention","volume":"34","author":"Escalera E","year":"2025","unstructured":"Escalera E, Saver JL. Magnitude of effect of low dose colchicine, a newly food and drug administration approved treatment for stroke prevention. J Stroke Cerebrovasc Dis. 2025, 34:108186. 10.1016\/j.jstrokecerebrovasdis.2024.108186","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-024-02026-5","article-title":"Update on the role of colchicine in cardiovascular disease","volume":"26","author":"Banco D","year":"2024","unstructured":"Banco D, Mustehsan M, Shah B. Update on the role of colchicine in cardiovascular disease. Curr Cardiol Rep. 2024, 26:191-8. 10.1007\/s11886-024-02026-5","journal-title":"Curr Cardiol Rep"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2024.01.004","article-title":"The impact of colchicine on patients with acute and chronic coronary artery disease","volume":"125","author":"Madanchi M","year":"2024","unstructured":"Madanchi M, Young M, Tersalvi G, et al.. The impact of colchicine on patients with acute and chronic coronary artery disease. Eur J Intern Med. 2024, 125:1-9. 10.1016\/j.ejim.2024.01.004","journal-title":"Eur J Intern Med"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1097\/CRD.0000000000000723","article-title":"Role of colchicine in cardiovascular disorders","author":"Moras E","year":"2024","unstructured":"Moras E, Subramanian L, Romeo F, et al.. Role of colchicine in cardiovascular disorders. Cardiol Rev. 2024, 10.1097\/CRD.0000000000000723","journal-title":"Cardiol Rev"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/433892-a-systematic-review-on-the-effect-of-colchicine-in-cardiovascular-disease-management-from-risk-reduction-to-comprehensive-care","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T07:39:12Z","timestamp":1764229152000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/433892-a-systematic-review-on-the-effect-of-colchicine-in-cardiovascular-disease-management-from-risk-reduction-to-comprehensive-care"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":63,"URL":"https:\/\/doi.org\/10.7759\/cureus.97903","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,26]]}}}